Reports
Reports
Sale
The global wound care market was valued at USD 22.05 billion in 2023, driven by the increasing prevalence of chronic wounds across the globe. The market size is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 34.21 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advanced wound care products are intended to heal and treat complicated injuries such as venous ulcers, foot ulcers, along with stress ulcers. The increasing incidence of hard-to-heal injuries and increasing acceptance of the product in the healthcare sector are driving the growth of the industry. The developments and innovations in the industry, coupled with growing prevalence of diabetes, rapid growth in the geriatric population, and increasing funding for research are the driving factors which are accelerating the growth of wound care industry. Moreover, an increasing number of road accidents and trauma injuries globally, and growing awareness programs for wound care treatment and management across impact the market growth positively. The high cost of advanced products and risks associated with the products are the drawbacks that may affect the wound care market growth in the forecast period.
Strategic Collaborations Between Market Players Propelling Market Growth
In March 2023, Bactiguard, a global MedTech company specialising in the development of biocompatible technologies that prevent medical device-related infections launched its wound care range in the UK and Ireland, in collaboration with Quintess Medical and GS Medical. Healing of a wound becomes challenging when bacteria along with other microorganisms develop in the wound. Wound dressings play a vital role in avoiding the discomfort caused by the bacteria. When compared to traditional wound management market, there is a shift towards biocompatible and pH-neutral products which support an improved wound healing process. They also clean the wound by reducing the microbial load. The Bactiguard product line can be used for both acute and chronic wounds as it is categorised as a non-toxic and environmentally friendly class III medical device.
The market is expected to be propelled by such collaborations as they expand the cross-regional market presence of healthcare’s leading players and make the company offerings available in other regions as well. This collaboration is poised to further strengthen Bactiguard’s position in the advanced wound care market, bolstering the market growth.
Escalating Financial Support Bolstering Market Growth
The market is receiving significant financial support boosting the development of novel products in the market. It is witnessing escalating demand for advanced wound care in every domain including military settings. For instance, in January 2024, 3M Health Care's Medical Solutions Division, the world leader in advanced wound care, received financial support of USD 34.2 million from the U.S. Army Medical Research Acquisition Activity. The fund has been offered to the company to develop a range of new solutions for infection prevention, wound management, and wound healing.
The wound dressing market is anticipated to be influenced positively by such strategic investments. The financial support will enable research activities for the development of novel solutions in advanced wound care leading to the availability of enhanced solutions. 3M will work on a program focused on strategies of treatment that can be used in critical settings. The program will work to assess biofilm control, biomarker monitoring, and healing in acute trauma situations such as blasts, burns, and gunshot wounds that occur in civilian and military settings. It will also work for both civilians and military settings and enable wide applications. The development of such novel solutions may also increase wound dressing market demand and strengthen the company’s market position.
Continuous Comprehension and Co-operation from Regulatory Authorities
The increasing demand for advanced wound care products in the market has resulted in a comprehension of the situation by the regulatory authorities. With increasing chronic injuries globally, the need to develop advanced wound care products and devices is necessary. With continuous efforts by market players, regulatory authorities like the US FDA (United States Food and Drug Administration) also play a crucial role in market growth. In April 2024, PowerHeal™, a bioelectric bandage that was approved by the Food and Drug Administration (FDA) for over the counter (OTC) use for wound management, was made available by Vomaris.
It is indicated for superficial wounds such as minor cuts, scrapes, irritations, abrasions, and blisters and is available in a variety of sizes. It minimizes the risk of infection and is FDA approved backed by the notable results from RCTs which adds to the credibility of the product. All these factors are likely to augment the advanced wound therapy devices market share in the forecast period. The FDA approval was based on multiple clinical trials demonstrating the efficacy of the bioelectric bandage, comparing the wireless electroceutical dressing (WED) to the standard of care treatment (such as debridement, negative pressure wound therapy, skin grafting) in 38 patients with burn wounds.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Research and Development Activities
The market is witnessing increasing research and development activities by researchers to develop new products and wound dressing effective enough to provide enhanced patient outcomes, propelling market demand.
Product Development
Several market players are putting continuous efforts toward innovating wound care for healthcare professionals and patients. The market is witnessing a rising trend toward the development of personalized wound care and multiple product launches in the market.
Increasing FDA Approvals
The wound care industry statistics reveal that several innovative wound care dressings and devices are being developed by major market players. Hence, regulatory bodies like United States FDA are providing approvals to bring latest and efficient treatment alternatives to patients. It is also triggering market competition and providing opportunities to other market players as well.
Recent Developments in the Market
In April 2024, a world leading MedTech company specialised in wound care and wound management, Mölnlycke Health Care, announced the acquisition of P.G.F. Industry Solutions GmbH, the Austrian manufacturer of Granudacyn wound cleansing and moisturizing solutions. Mölnlycke and P.G.F. have worked together for five years on the manufacturing and distribution of Granudacyn, a range of solution and gel products intended for use in the cleansing, irrigation, and moisturisation of various wound types. The high quality and composition of Granudacyn ensures good biocompatibility, allowing it to be effectively used on a broad range of tissues in burns, as well as acute and chronic wounds.
This strategic acquisition of P.G.F by Mölnlycke Health Care is dedicated to facilitating different types of wound care management. Following the acquisition, Mölnlycke Health Care will gain access to the outstanding product portfolio of P.G.F and trigger competition among other market players in the market. When the expertise and resources of both companies are integrated, it may likely lead to the enhanced innovation and development of new wound care products in the market expanding the market size.
In April 2023, the innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, was approved by the Food and Drug Administration (FDA) for hydromechanical removal of infectious materials, non-viable tissue and wound debris. This reduces the need for surgical debridement while promoting the formation of granulation tissue, creating an environment that supports wound healing. The FDA approval adds credibility to the therapy and plays a crucial role in making it available to healthcare providers and patients, thereby impacting the market positively.
Market Breakup by Product Type
Market Breakup by Wound Type
Market Breakup by Mode of Purchase
Market Breakup by End User
Market Breakup by Region
Market Segmentation by Product Type Poised to Experience Substantial Growth
Based on product type segmentation, the global wound care market is broadly segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound care devices. Advanced wound care includes personalized treatments for chronic wounds or the ones that couldn’t heal through traditional wound care. With increasing efforts of researchers and pharmaceutical companies to develop advanced wound dressings including foam dressing, hydrocolloid dressing, and hydrogel dressings, among other advanced dressings, the wound dressing market is expected to witness an upward trajectory in the forecast period. Advanced wound care dressings are also poised to rapidly grow due to the increasing demand for advanced and effective wound care suitable for both homecare and hospital settings.
Chronic Wounds are Likely to Account for a Significant Market Share Based on Wound Types
Based on the wound care market analysis, the segmentation based on wound types is divided into chronic and acute wounds. Chronic wounds such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others are expected to account for a notable market value. The rising prevalence of chronic diseases such as diabetes and conditions associated with it like foot ulcers and venous ulcers among others are contributing to the increased demand for specialized wound care to provide effective healing process and enhance patient outcomes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on regions, the market includes North America, Europe, Asia-Pacific, Latin America, along with Middle East and Africa. The market is dominated by North America due to the increasing prevalence of chronic injuries. The wound care market in U.S. is poised to experience increasing injuries led by rising prevalence of accidents and chronic diseases in the region. The market is further driven by the growing geriatric population. Moreover, the presence of several market players also contributes to the market value.
The wound care market in the UK is anticipated to be driven by the increasing development of new wound care dressings and devices. Apart from general wound care companies, the United Kingdom has around 66 advanced wound-care companies. Hence, the market value for advanced wound care is projected to bring several technically advanced wound care dressings and devices in the market. Moreover, fundings and investments from vital government bodies like National Health Service (NHS) is also impacting the market positively.
The Asia Pacific region, countries like China, Japan, and India account for a notable market share. The wound care market in India is growing, driven by the presence of a large patient pool and investments in medical research and infrastructure to provide effective wound management. The country is experiencing an increasing prevalence of diabetes leading to chronic wounds such as diabetic foot ulcers, which is demanding for effective and advanced wound care management devices. The rising number of road accidents are also contributing to the market growth.
The Middle East and Africa wound care market is experiencing growth due to rising healthcare investments and increasing awareness about wound care management. Countries in this region are adopting advanced wound care technologies to improve patient care.
The key features of the market report include patent analysis, and strategic initiatives which includes recent partnerships, collaborations and acquisitions by the leading players. The major companies in the market are as follows:
3M Company
The company was founded in 1902 and is headquartered in Minnesota, United States. The company specialises in several domains including healthcare including medical devices and supplies, health information systems, oral care, personal protective equipment (PPE), drug delivery systems, healthcare manufacturing and safety solutions, and healthcare adhesives. In March 2024, 3M announced the approval of its planned spin-off healthcare business Solventum Corporation.
Smith & Nephew plc
Founded in 1856, the company is headquartered in Hertfordshire, England. It is a medical equipment manufacturing company specialising in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction, sports medicine, robotics, ENT, trauma, hip replacement, knee replacement, extremities, negative pressure wound therapy, ligament repair, and exudate management.
Coloplast A/S
Founded in 1957, Coloplast is headquartered in Humlebæk, Denmark. It develops products and services to make life easier for people with personal and private medical conditions commonly associated with trauma and taboos. Coloplast A/S works in ostomy care, continence care, wound and skin care, interventional urology, voice and respiratory care. In January 2024, the company launched Biatain® Silicone Fit, an innovation in advanced wound care under the foam dressing segment addressing the needs of both the advanced and traditional wound management market.
Mölnlycke Health Care AB
Established in 1849, the company is headquartered in Gothenburg, Sweden. It is a human centric MedTech company specialising in innovative healthcare solutions for wound care and surgical procedures. Mölnlycke operates in O.R. efficiency, antiseptics, surgical gloves, surgical drapes, surgical staff clothing, custom procedure trays, dressings with safetac technology, pressure ulcer prevention, wound treatment, medical solutions, wound management, surgical solutions, and wound care.
ConvaTec Group plc.
Founded in 1978, the company is headquartered in London, England. It is a medical equipment manufacturing company specialising in wound therapeutics, ostomy care, continence and critical care, infusion devices, medical devices, healthcare, hospitals, engineering, commercial, and research and development. In May 2024, Convatec, a leading global medical products and technologies company announced clinical study results from a recent multinational randomised controlled trial (RCT). The results highlighted the notable advancements in the healing of venous leg ulcers with AQUACEL® Ag+ Extra™ compared to traditional dressing.
Other players in the market include Integra LifeSciences Holdings Corporation, Medtronic PLC, Johnson and Johnson Services, Inc., B. Braun Melsungen AG, Paul Hartmann AG, and Cardinal Health.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Wound Type |
|
Breakup by Mode of Purchase |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Wound Care Market Overview
3.1 Global Wound Care Market Historical Value (2017-2023)
3.2 Global Wound Care Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Wound Care Market Landscape*
5.1 Global Wound Care: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Wound Care: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Wound Type
6 Global Wound Care Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Wound Care Market, Epidemiology Snapshot
7.1 Overview of global Wound Care Incidence Number (2017-2032)
7.2 Incidence Number, By Indication (2017-2032)
7.2.1 Chronic Wounds
7.2.2 Acute Wounds
8 Global Wound Care Market Segmentation (2017-2032)
8.1 Global Wound Care Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Advanced Wound Dressing
8.1.2.1 Foam Dressing
8.1.2.2 Hydrocolloid Dressing
8.1.2.3 Film Dressing
8.1.2.4 Alginate Dressing
8.1.2.5 Hydrogel Dressing
8.1.2.6 Collagen Dressing
8.1.2.7 Other Advanced Dressing
8.1.3 Surgical Wound Care
8.1.3.1 Sutures & Staples
8.1.3.2 Tissue Adhesive and Sealants
8.1.3.3 Anti-Infective Dressing
8.1.3.4 Others
8.1.4 Traditional Wound Care
8.1.4.1 Medical Tapes
8.1.4.2 Cotton
8.1.4.3 Bandages
8.1.4.4 Gauzes
8.1.4.5 Sponges
8.1.4.6 Cleansing Agents
8.1.4.7 Others
8.1.5 Wound Care Devices
8.1.5.1 Negative Pressure Wound Therapy (NPWT)
8.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
8.1.5.3 Electric Stimulation Devices
8.1.5.4 Relief Devices
8.1.5.5 Wound Closure Devices
8.1.5.6 Others
8.2 Global Wound Care Market (2017-2032) by Wound Type
8.2.1 Market Overview
8.2.2 Chronic Wounds
8.2.2.1 Diabetic Foot Ulcers
8.2.2.2 Pressure Ulcers
8.2.2.3 Venous Leg Ulcers
8.2.2.4 Other Chronic Wounds
8.2.3 Acute Wound
8.2.3.1 Surgical & Traumatic Wounds
8.2.3.2 Burns
8.2.3.3 Others
8.3 Global Wound Care Market (2017-2032) by Mode of Purchase
8.3.1 Market Overview
8.3.2 Prescription Based
8.3.3 Non-Prescribed
8.4 Global Wound Care Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Ambulatory Surgical Centers
8.4.4 Specialty Clinics
8.4.5 Homecare Settings
8.4.6 Others
8.5 Global Wound Care Market (2017-2032) by Region
8.5.1 Market Overview
8.5.2 North America
8.5.3 Europe
8.5.4 Asia Pacific
8.5.5 Latin America
8.5.6 Middle East and Africa
9 North America Wound Care Market (2017-2032)
9.1 North America Wound Care Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Advanced Wound Dressing
9.1.2.1 Foam Dressing
9.1.2.2 Hydrocolloid Dressing
9.1.2.3 Film Dressing
9.1.2.4 Alginate Dressing
9.1.2.5 Hydrogel Dressing
9.1.2.6 Collagen Dressing
9.1.2.7 Other Advanced Dressing
9.1.3 Surgical Wound Care
9.1.3.1 Sutures & Staples
9.1.3.2 Tissue Adhesive and Sealants
9.1.3.3 Anti-Infective Dressing
9.1.3.4 Others
9.1.4 Traditional Wound Care
9.1.4.1 Medical Tapes
9.1.4.2 Cotton
9.1.4.3 Bandages
9.1.4.4 Gauzes
9.1.4.5 Sponges
9.1.4.6 Cleansing Agents
9.1.4.7 Others
9.1.5 Wound Care Devices
9.1.5.1 Negative Pressure Wound Therapy (NPWT)
9.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
9.1.5.3 Electric Stimulation Devices
9.1.5.4 Relief Devices
9.1.5.5 Wound Closure Devices
9.1.5.6 Others
9.2 North America Wound Care Market (2017-2032) by Wound Type
9.2.1 Market Overview
9.2.2 Chronic Wounds
9.2.2.1 Diabetic Foot Ulcers
9.2.2.2 Pressure Ulcers
9.2.2.3 Venous Leg Ulcers
9.2.2.4 Other Chronic Wounds
9.2.3 Acute Wound
9.2.3.1 Surgical & Traumatic Wounds
9.2.3.2 Burns
9.2.3.3 Others
9.3 North America Wound Care Market (2017-2032) by Mode of Purchase
9.3.1 Market Overview
9.3.2 Prescription Based
9.3.3 Non-Prescribed
9.4 North America Wound Care Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Ambulatory Surgical Centers
9.4.4 Specialty Clinics
9.4.5 Homecare Settings
9.4.6 Others
9.5 North America Wound Care Market (2017-2032) by Country
9.5.1 United States of America
9.5.2 Canada
10 Europe Wound Care Market (2017-2032)
10.1 Europe Wound Care Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Advanced Wound Dressing
10.1.2.1 Foam Dressing
10.1.2.2 Hydrocolloid Dressing
10.1.2.3 Film Dressing
10.1.2.4 Alginate Dressing
10.1.2.5 Hydrogel Dressing
10.1.2.6 Collagen Dressing
10.1.2.7 Other Advanced Dressing
10.1.3 Surgical Wound Care
10.1.3.1 Sutures & Staples
10.1.3.2 Tissue Adhesive and Sealants
10.1.3.3 Anti-Infective Dressing
10.1.3.4 Others
10.1.4 Traditional Wound Care
10.1.4.1 Medical Tapes
10.1.4.2 Cotton
10.1.4.3 Bandages
10.1.4.4 Gauzes
10.1.4.5 Sponges
10.1.4.6 Cleansing Agents
10.1.4.7 Others
10.1.5 Wound Care Devices
10.1.5.1 Negative Pressure Wound Therapy (NPWT)
10.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
10.1.5.3 Electric Stimulation Devices
10.1.5.4 Relief Devices
10.1.5.5 Wound Closure Devices
10.1.5.6 Others
10.2 Europe Wound Care Market (2017-2032) by Wound Type
10.2.1 Market Overview
10.2.2 Chronic Wounds
10.2.2.1 Diabetic Foot Ulcers
10.2.2.2 Pressure Ulcers
10.2.2.3 Venous Leg Ulcers
10.2.2.4 Other Chronic Wounds
10.2.3 Acute Wound
10.2.3.1 Surgical & Traumatic Wounds
10.2.3.2 Burns
10.2.3.3 Others
10.3 Europe Wound Care Market (2017-2032) by Mode of Purchase
10.3.1 Market Overview
10.3.2 Prescription Based
10.3.3 Non-Prescribed
10.4 Europe Wound Care Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Ambulatory Surgical Centers
10.4.4 Specialty Clinics
10.4.5 Homecare Settings
10.4.6 Others
10.5 Europe Wound Care Market (2017-2032) by Country
10.5.1 United Kingdom
10.5.2 Germany
10.5.3 France
10.5.4 Italy
10.5.5 Others
11 Asia Pacific Wound Care Market (2017-2032)
11.1 Asia Pacific Wound Care Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Advanced Wound Dressing
11.1.2.1 Foam Dressing
11.1.2.2 Hydrocolloid Dressing
11.1.2.3 Film Dressing
11.1.2.4 Alginate Dressing
11.1.2.5 Hydrogel Dressing
11.1.2.6 Collagen Dressing
11.1.2.7 Other Advanced Dressing
11.1.3 Surgical Wound Care
11.1.3.1 Sutures & Staples
11.1.3.2 Tissue Adhesive and Sealants
11.1.3.3 Anti-Infective Dressing
11.1.3.4 Others
11.1.4 Traditional Wound Care
11.1.4.1 Medical Tapes
11.1.4.2 Cotton
11.1.4.3 Bandages
11.1.4.4 Gauzes
11.1.4.5 Sponges
11.1.4.6 Cleansing Agents
11.1.4.7 Others
11.1.5 Wound Care Devices
11.1.5.1 Negative Pressure Wound Therapy (NPWT)
11.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
11.1.5.3 Electric Stimulation Devices
11.1.5.4 Relief Devices
11.1.5.5 Wound Closure Devices
11.1.5.6 Others
11.2 Asia Pacific Wound Care Market (2017-2032) by Wound Type
11.2.1 Market Overview
11.2.2 Chronic Wounds
11.2.2.1 Diabetic Foot Ulcers
11.2.2.2 Pressure Ulcers
11.2.2.3 Venous Leg Ulcers
11.2.2.4 Other Chronic Wounds
11.2.3 Acute Wound
11.2.3.1 Surgical & Traumatic Wounds
11.2.3.2 Burns
11.2.3.3 Others
11.3 Asia Pacific Wound Care Market (2017-2032) by Mode of Purchase
11.3.1 Market Overview
11.3.2 Prescription Based
11.3.3 Non-Prescribed
11.4 Asia Pacific Wound Care Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Ambulatory Surgical Centers
11.4.4 Specialty Clinics
11.4.5 Homecare Settings
11.4.6 Others
11.5 Asia Pacific Wound Care Market (2017-2032) by Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 ASEAN
11.5.5 Australia
11.5.6 Others
12 Latin America Wound Care Market (2017-2032)
12.1 Latin America Wound Care Market (2017-2032) by Product Type
12.1.1 Market Overview
12.1.2 Advanced Wound Dressing
12.1.2.1 Foam Dressing
12.1.2.2 Hydrocolloid Dressing
12.1.2.3 Film Dressing
12.1.2.4 Alginate Dressing
12.1.2.5 Hydrogel Dressing
12.1.2.6 Collagen Dressing
12.1.2.7 Other Advanced Dressing
12.1.3 Surgical Wound Care
12.1.3.1 Sutures & Staples
12.1.3.2 Tissue Adhesive and Sealants
12.1.3.3 Anti-Infective Dressing
12.1.3.4 Others
12.1.4 Traditional Wound Care
12.1.4.1 Medical Tapes
12.1.4.2 Cotton
12.1.4.3 Bandages
12.1.4.4 Gauzes
12.1.4.5 Sponges
12.1.4.6 Cleansing Agents
12.1.4.7 Others
12.1.5 Wound Care Devices
12.1.5.1 Negative Pressure Wound Therapy (NPWT)
12.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
12.1.5.3 Electric Stimulation Devices
12.1.5.4 Relief Devices
12.1.5.5 Wound Closure Devices
12.1.5.6 Others
12.2 Latin America Wound Care Market (2017-2032) by Wound Type
12.2.1 Market Overview
12.2.2 Chronic Wounds
12.2.2.1 Diabetic Foot Ulcers
12.2.2.2 Pressure Ulcers
12.2.2.3 Venous Leg Ulcers
12.2.2.4 Other Chronic Wounds
12.2.3 Acute Wound
12.2.3.1 Surgical & Traumatic Wounds
12.2.3.2 Burns
12.2.3.3 Others
12.3 Latin America Wound Care Market (2017-2032) by Mode of Purchase
12.3.1 Market Overview
12.3.2 Prescription Based
12.3.3 Non-Prescribed
12.4 Latin America Wound Care Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Hospitals
12.4.3 Ambulatory Surgical Centers
12.4.4 Specialty Clinics
12.4.5 Homecare Settings
12.4.6 Others
12.5 Latin America Wound Care Market (2017-2032) by Country
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Mexico
12.5.4 Others
13 Middle East and Africa Wound Care Market (2017-2032)
13.1 Middle East and Africa Wound Care Market (2017-2032) by Product Type
13.1.1 Market Overview
13.1.2 Advanced Wound Dressing
13.1.2.1 Foam Dressing
13.1.2.2 Hydrocolloid Dressing
13.1.2.3 Film Dressing
13.1.2.4 Alginate Dressing
13.1.2.5 Hydrogel Dressing
13.1.2.6 Collagen Dressing
13.1.2.7 Other Advanced Dressing
13.1.3 Surgical Wound Care
13.1.3.1 Sutures & Staples
13.1.3.2 Tissue Adhesive and Sealants
13.1.3.3 Anti-Infective Dressing
13.1.3.4 Others
13.1.4 Traditional Wound Care
13.1.4.1 Medical Tapes
13.1.4.2 Cotton
13.1.4.3 Bandages
13.1.4.4 Gauzes
13.1.4.5 Sponges
13.1.4.6 Cleansing Agents
13.1.4.7 Others
13.1.5 Wound Care Devices
13.1.5.1 Negative Pressure Wound Therapy (NPWT)
13.1.5.2 Oxygen And Hyperbaric Oxygen Equipment
13.1.5.3 Electric Stimulation Devices
13.1.5.4 Relief Devices
13.1.5.5 Wound Care Devices
13.1.5.6 Others
13.2 Middle East and Africa Wound Care Market (2017-2032) by Wound Type
13.2.1 Market Overview
13.2.2 Chronic Wounds
13.2.2.1 Diabetic Foot Ulcers
13.2.2.2 Pressure Ulcers
13.2.2.3 Venous Leg Ulcers
13.2.2.4 Other Chronic Wounds
13.2.3 Acute Wound
13.2.3.1 Surgical & Traumatic Wounds
13.2.3.2 Burns
13.2.3.3 Others
13.3 Middle East and Africa Wound Care Market (2017-2032) by Mode of Purchase
13.3.1 Market Overview
13.3.2 Prescription Based
13.3.3 Non-Prescribed
13.4 Middle East and Africa Wound Care Market (2017-2032) by End User
13.4.1 Market Overview
13.4.2 Hospitals
13.4.3 Ambulatory Surgical Centers
13.4.4 Specialty Clinics
13.4.5 Homecare Settings
13.4.6 Others
13.5 Middle East and Africa Wound Care Market (2017-2032) by Country
13.5.1 Saudi Arabia
13.5.2 United Arab Emirates
13.5.3 Nigeria
13.5.4 South Africa
13.5.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 3M Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Smith & Nephew plc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Integra LifeSciences Holdings Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Mölnlycke Health Care AB
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 ConvaTec Group plc .
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Coloplast A/S
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Johnson and Johnson Services, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 B. Braun Melsungen AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Paul Hartmann AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cardinal Health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Wound Care Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
*The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.